<DOC>
	<DOCNO>NCT02774174</DOCNO>
	<brief_summary>This study single centre , non-randomised , post market clinical follow examine retrospective patient data series surgical cases; involve endoprosthetic replacement proximal humerus use Stanmore Implant Worldwide METS ( Modular Endoprosthetic Tumour System ) Proximal Humeral system . The objective study evaluate retrospective patient data patient follow least 12 month post operation; demonstrate safety METS Proximal Humeral replacement system .</brief_summary>
	<brief_title>The Evaluation METS™ Proximal Humeral System</brief_title>
	<detailed_description>The METS™ Proximal Humeral system endoprosthetic replacement design restore length function arm resection significant amount bone tissue ; due malignant tumour proximal humerus . This Post Market Clinical Follow ( PMCF ) study design support exist evidence system safe performs expect , analyse retrospective patient data METS™ Proximal Humeral replacement . The target population male female subject age 18 year implant METS™ Proximal Humeral system Royal National Orthopaedic Hospital , Stanmore ; patient follow least 12 month follow implantation .</detailed_description>
	<criteria>1 . Patient age 18 implanted METS™ Proximal Humeral system implant Royal National Orthopaedic Hospital , Stanmore . 2 . Patient follow least 12 month follow implant surgery 3 . Patient surgery January 2007 1 . Patient currently involve pending litigation worker 's compensation 2 . Patient participate another clinical investigation study investigational medical device within last 60 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Proximal Humerus</keyword>
</DOC>